Keywords: texas, biotech, stock, offering, biotechnology, seeking, million

TEXAS BIOTECH STOCK OFFERING

Article | 06 December 1993

Print This

- Texas Biotechnology is seeking $15.8 million via an initial public offering to fund trials of the thrombin inhibitor argatroban, and two ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in